Home › Funds › Concorde Financial Corp › JNJ

Concorde Financial Corp position in JNJ

JOHNSON & JOHNSON · Health Care

Concorde Financial Corp reported holding 27,510 shares of JNJ (JOHNSON & JOHNSON) in its Q2 2026 13F filing — a position valued at US$7.0M, representing 5.63% of its reported portfolio and ranking #4 among its reported holdings. Concorde Financial Corp has disclosed JNJ holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)27.51K sh
Reported value held$6.99M
Portfolio Weight5.63%
First reportedQ3 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Concorde Financial Corp's JNJ position evolved

Concorde Financial Corp first disclosed a stake in JNJ in Q3 2023 at 4,800 shares (US$748K). The position peaked in Q2 2026 at 27,510 shares, worth US$7.0M. Across 12 filings, Concorde Financial Corp increased the stake 6 time(s), trimmed it 3 time(s) and left it unchanged 2 time(s). The most recent filing (Q2 2026) shows 27,510 shares valued at US$7.0M — an increase of 1,086 shares quarter over quarter.. Notable position changes include a 432% increase in Q4 2023 (shares rose 1% over the following quarter), a 81% trim in Q1 2024 (shares fell 8% over the following quarter), a 451% increase in Q2 2024 (shares rose 11% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 4.80K $747.60K New
Q4 2023 25.55K $4.00M Add
Q1 2024 4.80K $759.31K Reduce
Q2 2024 26.45K $3.87M Add
Q3 2024 29.13K $4.72M Add
Q4 2024 29.22K $4.23M Hold
Q1 2025 29.41K $4.88M Add
Q2 2025 29.22K $4.46M Reduce
Q3 2025 29.28K $5.43M Hold
Q4 2025 26.05K $6.07M Reduce
Q1 2026 26.42K $6.46M Add
Q2 2026 27.51K $6.99M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JNJ and 13F data

JNJ (JOHNSON & JOHNSON) is a Health Care company. 33 other funds we track also report a position in JNJ — the largest reported positions include BlackRock Inc (US$53.87B), Vanguard Group (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$39.93B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JNJ

All JNJ fund holders →

FAQ

How long has Concorde Financial Corp held JNJ?

Concorde Financial Corp has disclosed JNJ holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is Concorde Financial Corp's current position in JNJ?

As of Q2 2026, Concorde Financial Corp holds 27.51K shares of JNJ (JOHNSON & JOHNSON), valued at $6.99M, representing 5.63% of its reported portfolio and ranking #4.

Has Concorde Financial Corp been buying or selling JNJ?

In the latest 13F filing (Q2 2026), Concorde Financial Corp increased its position in JNJ. The position peaked in Q2 2026 at 27.51K shares.

Which other funds hold JNJ?

Other major institutional holders of JNJ include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 33 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.